first largescale malaria vaccine trials
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

For Africa

First Large-Scale Malaria Vaccine Trials

Arab Today, arab today

Arab Today, arab today First Large-Scale Malaria Vaccine Trials

A new malaria vaccine will be tested
New York - Arab Today

A new malaria vaccine will be tested on a large scale in Kenya, Ghana and Malawi, the World Health Organization said Monday, with 360,000 children to be vaccinated between 2018 and 2020.

The injectable vaccine RTS,S could provide limited protection against a disease that killed 429,000 people worldwide in 2015, with 92 percent of victims in Africa and two-thirds of them children under five.

"The prospect of a malaria vaccine is great news. Information gathered in the pilot will help us make decisions on the wider use of this vaccine," said Dr Matshidiso Moeti, the WHO's regional director for Africa.

The vaccine should be used alongside other preventative measures such as bed nets, insecticides, repellants and anti-malarial drugs, the WHO said.

"Combined with existing malaria interventions, such a vaccine would have the potential to save tens of thousands of lives in Africa," Moeti said.

The vaccine, also known as Mosquirix, has been developed by the British pharmaceutical giant GlaxoSmithKline (GSK) in partnership with the PATH Malaria Vaccine Initiative, and the large-scale three-country pilot will test it on children aged five to 17 months.

The drug passed previous scientific testing -- including a phase three clinical trial between 2009 and 2014 -- and was approved for the pilot programme in 2015.

- 'Huge impact' -The aim of the trial is to assess the effectiveness of the vaccine as well the feasibility of its delivery to populations at risk as four successive doses must be given on a strict timetable.

The immunisation cycle is not in sync with routine childhood inoculations against diseases such as hepatitis, measles and meningitis, with injections required at five months, six months, seven months and two years.

Symptoms of malaria include fever, muscle pain and headache as well as vomiting and diarrhoea.

While RTS,S does not promise full protection against the mosquito-borne disease it is the most effective potential vaccine so far developed, reducing the number of malaria episodes by 40 percent in tests on 15,000 people over five years of clinical trials, and could therefore save hundreds of thousands of lives.

"It's an efficacy rate which is quite low, but given the amount of affected people, the impact will be huge," said Mary Hamel, who is coordinating the vaccine's implementation programme.

"There will be other vaccines and they'll be more efficient, but in the meantime, this will have a significant influence."

Kenya, Ghana and Malawi were selected for the trial because malaria rates are high and they have a long history of use of bed nets and other interventions.

The large-scale pilot is the latest step in decades of work seeking to eradicate malaria with the numbers dying falling nearly two-thirds since the turn of the century.

Source: AFP

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

first largescale malaria vaccine trials first largescale malaria vaccine trials

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

first largescale malaria vaccine trials first largescale malaria vaccine trials

 



GMT 13:25 2017 Tuesday ,07 March

Received offer to join Ahly

GMT 11:36 2017 Saturday ,26 August

PT Pupuk Indonesia to produce competitive products

GMT 03:13 2017 Tuesday ,07 March

Tadweer celebrates National Environment Day

GMT 05:51 2017 Thursday ,10 August

Israeli forces shoot a Palestinian in head

GMT 09:26 2017 Tuesday ,14 February

Kuwaiti MP wants medical insurance for expats

GMT 23:05 2017 Monday ,27 February

Iraq forces reach key Mosul bridge

GMT 02:15 2017 Friday ,14 April

Football bus attacker was IS member in Iraq

GMT 17:41 2016 Thursday ,28 July

2 Gunmen Killed in Clashes in Tunisia

GMT 12:29 2017 Monday ,13 November

Lauda warns about future of F1 under new owners

GMT 02:24 2017 Saturday ,14 October

September24th-October23rd

GMT 10:29 2017 Friday ,01 September

King, Turkish president exchange Eid greetings

GMT 14:05 2017 Monday ,30 January

2 Egyptian candidates vying for AU commissioners

GMT 11:36 2017 Saturday ,29 July

Nature store sells handmade products from reserves

GMT 09:10 2017 Saturday ,25 November

EU, ex-Soviet states push ties

GMT 14:15 2017 Tuesday ,10 October

Uber puts the brakes on UberPOP

GMT 17:52 2018 Wednesday ,24 October

PM Giuseppe Conte invites Putin to visit Italy

GMT 13:07 2018 Saturday ,08 September

Roscosmos, NASA to enter into talks on future of ISS

GMT 02:16 2018 Friday ,19 January

Time for talks on players' welfare

GMT 06:53 2018 Tuesday ,02 January

Omani Prosecutor General Arrives in Khartoum
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday